Related Experiment Videos
Receptors for ADP on human blood platelets
1School of Biological Sciences, University of Surrey, Guildford, UK.
Trends in Pharmacological Sciences
|April 1, 1994
Summary
Adenosine diphosphate (ADP) triggers human platelet aggregation, but its precise signaling pathways remain unclear. This review explores conflicting evidence on ADP receptors to clarify platelet activation mechanisms.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Adenosine diphosphate (ADP) is a primary inducer of human blood platelet aggregation.
- The exact mechanisms by which ADP activates platelets and the specific signal transduction pathways involved are not fully understood.
- The existence and nature of ADP receptors on platelets are subjects of ongoing debate.
Purpose of the Study:
- To review and analyze conflicting evidence regarding ADP's effects on human platelets.
- To investigate the number and characteristics of ADP receptors on human platelets.
- To propose tentative conclusions about ADP receptor signaling in platelet activation.
Main Methods:
- Literature review of existing research on ADP and platelet function.
- Analysis of conflicting experimental data concerning platelet aggregation and signaling.
- Synthesis of evidence to evaluate hypotheses about ADP receptor subtypes and their roles.
Main Results:
- Evidence suggests that intracellular calcium (Ca2+) concentration increases are critical for platelet activation by ADP.
- The precise mechanisms linking ADP to calcium increases and other signaling events require further elucidation.
- Conflicting data exists regarding whether ADP interacts with a single receptor type or multiple distinct receptors on platelets.
Conclusions:
- The precise number and types of ADP receptors on human platelets are still under investigation.
- Understanding ADP receptor function is crucial for comprehending platelet activation and developing targeted therapies.
- Further research is needed to resolve discrepancies and establish a definitive model of ADP signaling in platelets.